NCT00510809 is a NA clinical trial of Policosanol in High Cholesterol, sponsored by James Backes, PharmD.

Who is sponsoring NCT00510809?

NCT00510809 is sponsored by James Backes, PharmD.

What drugs are being tested in NCT00510809?

Interventions in NCT00510809: Policosanol, Placebo, Policosanol Plus Already In Use Statin Therapy.

What condition does NCT00510809 study?

NCT00510809 studies High Cholesterol.

Is NCT00510809 still recruiting?

NCT00510809 is currently completed. Last updated 22 September 2015.

Are results published for NCT00510809?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2015-09-22 · How we verify

NCT00510809

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Efficacy of Policosanol Monotherapy and When Added to Chronic Statin Therapy: A Pilot Study

Completed NA Results posted Last updated 22 September 2015

What this trial tests

NA trial testing Policosanol in High Cholesterol in 54 participants. Completed in 1 May 2010.

Timeline

1 July 2007

Primary endpoint
1 March 2010

1 May 2010

Quick facts

Lead sponsor	James Backes, PharmD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	54
Start date	1 July 2007
Primary completion	1 March 2010
Estimated completion	1 May 2010
Sites	1 location across United States

Drugs / interventions tested

Policosanol — full drug profile →
Placebo
Policosanol Plus Already In Use Statin Therapy — full drug profile →

Conditions studied

High Cholesterol — all drugs for High Cholesterol →

Sponsor

James Backes, PharmD — full company profile →

Who can join

Adults 18 to 75, any sex, with High Cholesterol. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Lipid Profile
Time frame: Change between Week 8 and Baseline

Sponsor's own description

To determine the effects of policosanol on the cholesterol profile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Policosanol

Trials testing the same drug.

NCT05365425 — Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia · Phase 4 · recruiting

Other recruiting trials for High Cholesterol

Currently open trials in the same condition.

NCT07220213 — FELLAShip to Better Health · NA · recruiting
NCT07126587 — Healthy Living Anson Study · NA · recruiting
NCT06364163 — Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults · NA · active not recruiting
NCT06192251 — Complete Lifestyle Medicine Intervention Program · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00510809 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by James Backes, PharmD
Last refreshed: 22 September 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00510809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing